Stockholders' Deficit |
9 Months Ended |
|---|---|
Sep. 30, 2018 | |
| Equity [Abstract] | |
| STOCKHOLDERS' DEFICIT | NOTE 9 – STOCKHOLDERS’ DEFICIT
Common Stock
During the nine months ended September 30, 2018, the Company sold 5,000,000 restricted shares of common stock at $0.01 per share for the total proceeds of $50,000. In addition, the Company granted 2,900,000 restricted shares of common stock at $0.01 in exchange for an amount owed ($29,000) to an independent consultant for business development services previously performed for the benefit of the Company. Finally, for the nine months ended September 30, 2018, the Company granted 94,394 restricted shares of common stock for business development services. The Company valued the shares based on the closing price of the Company common stock on those days during which such services were performed. This resulted in $750 of expense for the nine months ended September 30, 2018.
COMMON STOCK WARRANTS
The Company did not issue warrants for the nine months ended September 30, 2018 and 2017 and no warrants were exercised. As of September 30, 2018, there were no warrants outstanding. |